Drug Type CAR-T |
Synonyms- |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Triarm Therapeutics Ltd.Startup |
Active Organization Triarm Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | IND Approval | US | Triarm Therapeutics Ltd.Startup | 23 Oct 2023 |